Clinical Trials on Mild-To-Moderate Alzheimer's Disease

Total 7039 results

Instituto Nacional de Ciencias Medicas y Nutricion...

Completed

Acute Effect of Low-intensity Gamma rTMS on Cognitive and EEG Parameters in Adults With Mild Dementia by Alzheimer's Disease

Alzheimer Disease | Mild Dementia

Mexico
MEDA PHARMA SPA, a Viatris company

Not yet recruiting

Observational Study to Evaluate Use of Elidel® in South and East Asian Pediatric Patients With Atopic Dermatitis. (Elidel-SEA)

Mild to Moderate Atopic Dermatitis
Creabilis SA

Terminated

CT 327 in the Treatment of Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

Switzerland
University of Louisville
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative Colitis

Mild to Moderately Active Ulcerative Colitis

United States
Charite University, Berlin, Germany

Completed

Modification of Pavlovian and Instrumental Learning in Human Addiction

Healthy | Alcohol Use Disorder (Mild vs. Moderate to Heavy)

Germany
Egalet Ltd

Completed

Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain

Moderate-to-severe Chronic Noncancer Pain

United States
Westlake Pharmaceuticals (Hangzhou) Co., Ltd.

Recruiting

Phase III Clinical Study Evaluating the Efficacy and Safety of WPV01 in Patients With Mild/Moderate COVID-19

Mild to Moderate COVID-19

China
Ology Bioservices
Pharm-Olam, LLC; Chemical, Biological, Radiological, and Nuclear Medical

Withdrawn

Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT) (COMBAAT)

Mild to Moderate COVID-19
Kaleido Biosciences

Completed

A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function

Mild-to-Moderate COVID-19

United States
Kaleido Biosciences

Completed

A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19

Mild-to-moderate COVID-19

United States
Merz North America, Inc.

Completed

Evaluation of Pain With Belotero® Balance With Integral Lidocaine for Correction of the Nasolabial Folds

Correction of Moderate to Severe Nasolabial Folds

United States
University of North Carolina, Chapel Hill
National Institute on Aging (NIA)

Completed

Telephone-delivered Mindfulness Intervention for African American Dementia Caregivers

Alzheimer Dementia | Dementia Alzheimers | Caregiver

United States
Barcelonabeta Brain Research Center, Pasqual Maragall...

Recruiting

β-AARC: Cohort Study for the Identification of Blood-based Biomarkers in a Population With Subjective Cognitive Decline (β-AARC)

Alzheimer Disease | Mild Cognitive Impairment | Preclinical Alzheimer

Spain
Wake Forest University Health Sciences

Active, not recruiting

Eucrisa for Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

United States
Sterna Biologicals GmbH & Co. KG

Completed

Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema

Mild to Moderate Atopic Dermatitis

Germany
Bitop AG

Completed

Efficacy and Safety of an Ectoine-containing Cream in the Treatment of Mild to Moderate Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

Germany
HK inno.N Corporation

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients

Mild to Moderate Atopic Dermatitis
Greenpharma S.A.S.
Complife Italia S.r.l

Completed

A Controlled Study to Evaluate the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

Italy
HanAll BioPharma Co., Ltd.

Completed

Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

United States
Bayer

Completed

A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

Germany
Janssen Pharmaceutica

Withdrawn

A Safety and Effectiveness Study of Immediate Release Tapentadol Hydrochloride Among Filipino Patients With Moderate to Severe Acute Non-Cancer Pain

Moderate to Severe Acute Non-Cancer Pain
Shanghai JunTop Biosciences Co., LTD
Sponsor GmbH

Terminated

JT001 (VV116) for the Early Treatment of COVID-19

Mild to Moderate COVID-19

China, Hong Kong
Daewoong Pharmaceutical Co. LTD.

Terminated

Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo

Mild to Moderate COVID-19

Korea, Republic of
Oneness Biotech Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients

Mild to Moderate COVID-19

Taiwan, United States
Shanghai Vinnerna Biosciences Co., Ltd.
Sponsor GmbH

Completed

JT001 (VV116) for the Treatment of COVID-19

Mild to Moderate COVID-19

China
Guangdong Raynovent Biotech Co., Ltd

Completed

Study of RAY1216 Tablets Compared With Placebo in Patients With Mild to Moderate COVID-19

Mild to Moderate COVID-19

China
Novoic Limited

Not yet recruiting

Prediction of Amyloid and Mild Cognitive Impairment in Early Stage Alzheimer's Disease From Remote Speech Phenotyping (EARS)

Alzheimer Disease | Mild Cognitive Impairment | Alzheimer's Disease (Incl Subtypes)
BioPharmX, Inc.

Completed

Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea

Moderate to Severe Papulopustular Rosacea

United States
KoBioLabs
Novotech (Australia) Pty Limited

Completed

Study of Multiple Ascending Dose of KBL693 in Healthy Participants

Moderate to Severe Asthma

Australia
Massachusetts General Hospital
National Institutes of Health (NIH); National Institute on Aging (NIA)

Active, not recruiting

MASC: Reducing Stress for Caregivers (MASC)

Dementia Alzheimers | Alzheimer Disease and Related Dementias

United States
Washington University School of Medicine
Hoffmann-La Roche; Genentech, Inc.; National Institute on Aging (NIA); Alzheimer...

Suspended

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation (DIAN-TU)

Dementia | Alzheimers Disease | Alzheimers Disease, Familial

United States, Canada, Italy, France, Spain, Ireland, Argentina, Australia, Colombia, Germany, Mexico, Netherlands, Puerto Rico, United Kingdom
Alexandria University
Assoc. Prof. Ayman Ibrahim Baess; Dr. Noha Alaa Eldine Hassan Hamdy; Ph. Hanya...

Recruiting

Clinical Trial for Oral Formula of Vanillin and Wheat Germ Oil for Treatment of Mild and Moderate COVID-19 Viral Disease

Mild-to-moderate COVID-19

Egypt
Janssen Pharmaceutica

Withdrawn

A Safety and Effectiveness Study of Prolonged Release Tapentadol Hydrochloride Among Filipino Patients With Moderate to Severe Chronic Non-Cancer Pain

Moderate to Severe Chronic Non-cancer Pain
Abbott

Completed

Long Term Safety and Tolerability Study in Approximately 350 Subjects With Moderate to Severe Chronic, Non-malignant Pain

Moderate to Severe Chronic, Non-malignant Pain

United States
Guangzhou University of Traditional Chinese Medicine
Guangzhou Cadre Health Management Center

Recruiting

Proteomics Study of Mild Cognitive Impairment and Alzheimer's Disease

Alzheimer Disease, Early Onset | Protein; Disease

China
Kaohsiung Medical University Chung-Ho Memorial...
China Medical University, China

Active, not recruiting

Effect of Astaxanthin on the Patients With Alzheimer Disease

To Evaluate the Possible Benefit of Astaxanthin on Alzheimer Disease

Taiwan
Merck Sharp & Dohme LLC

Terminated

A Study of MK-6913 for the Treatment of Hot Flashes in Postmenopausal Women (6913-004)

Women | Moderate to Severe Vasomotor Symptoms in Postmenopausal
Frontier Biotechnologies Inc.

Recruiting

Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19

Mild to Moderate COVID-19

China
Inmune Bio, Inc.

Withdrawn

Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation

Mental Disorders | Brain Diseases | Central Nervous System Diseases | Nervous System Diseases | Neurodegenerative Diseases | Dementia | Mild Cognitive Impairment (MCI) | Alzheimer Disease | Tauopathies
Cytos Biotechnology AG

Completed

Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension

Mild Essential Hypertension | Moderate Essential Hypertension

Switzerland
Maastricht University
Radboud University Medical Center

Completed

Implementation of a Diagnostic Decision-aid for People With Memory Complaints and Their General Practitioners (S-DeciDeD)

Dementia | Dementia Alzheimers | Dementia, Mild

Netherlands
Mundipharma Research GmbH & Co KG

Completed

A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain

Subjects With Moderate to Severe, Chronic Nonmalignant Pain
Wake Forest University Health Sciences
The University of Texas Health Science Center at San Antonio

Recruiting

Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study (SToMP-AD)

Mild Cognitive Impairment | Alzheimer Disease, Early Onset

United States, Spain
Actavis Inc.

Completed

Clinical Endpoint Study of Ivermectin 1% Cream

Moderate to Severe Papulopustular Rosacea

United States
University College, London
Washington University School of Medicine; University of Washington; Alzheimer... and other collaborators

Not yet recruiting

A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK (NIO-SILK)

Alzheimer Disease | Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 1 (Disorder) | Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 2 (Disorder) | Autosomal Dominant Alzheimer Disease Due to Mutation of Amyloid Precursor Protein (Disorder)
ElMindA Ltd

Unknown

Reference Database & Longitudinal Registry of the Normal and Pathological Aging Brain ((BNA™))

Depression | Aging | Mild Cognitive Impairment | Early Onset Alzheimer Disease

United States
Eli Lilly and Company

Completed

A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)

Mild Cognitive Impairment (MCI) | Alzheimer Disease

United States
Indiana University
National Institute on Aging (NIA); Alzheimer's Therapeutic Research Institute; Alzheimer's Association

Recruiting

Longitudinal Early-onset Alzheimer's Disease Study Protocol (LEADS)

Alzheimer Disease | Mild Cognitive Impairment | Early Onset Alzheimer Disease

United States
Temple University

Recruiting

Improving Everyday Task Performance Through Repeated Practice in Virtual Reality. (VKI)

Dementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, Mild

United States
University of North Carolina, Chapel Hill
National Institute on Aging (NIA)

Enrolling by invitation

The Nightlight Falls Prevention Study

Alzheimer Disease | Aging | Fall Injury | Dementia Alzheimers | Dementia of Alzheimer Type

United States

Clinical Trials on Mild-To-Moderate Alzheimer's Disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations